(3) BCRP was the third identified major drug efflux pump in the ABC family, and elevated BCRP levels are associated with treatment failure of chemotherapy in cancers such as acute myelogenous leukemia (AML) and breast cancer 62, 73. This evidence concerns the gene ABCG2 and breast carcinoma.